Praxis Precision Medicines, Inc updated our SCN2A community on the status of their three SCN2A programs in development and their CIITIZEN partnership.
PRAX-562 PRAX-562 is currently in phase 1 clinical trials (meaning it is being tested in humans). This agent has completed
